Nigeria's Contraceptive Devices Market is expected to witness growth from $12 Mn in 2022 to $23 Mn in 2030 with a CAGR of 9.00% for the forecasted year 2022-30. Nigerian women and couples are becoming more aware of the value of family planning and the variety of contraceptive alternatives available to them. Demand for contraceptive products is projected to rise as public awareness of them rises. The market is segmented by type and by gender. Some key players in this market include Zolon Healthcare, Emzor Pharmaceutical, Alpha Pharmacy Nigeria, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
Netherlands's ECG Equipment Market is expected to witness growth from $23 Mn in 2022 to $42 Mn in 2030 with a CAGR of 7.80% for the forecasted year 2022-30. In the Netherlands, there is an increasing focus on preventative healthcare, which is anticipated to increase demand for ECG equipment as consumers take a more proactive approach to monitoring their cardiac health. The market is segmented by product type and by end user. Some key players in this market include Hy2Care B.V., InnoSer, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.
Netherlands's Coronary Stents Market is expected to witness growth from $29 Mn in 2022 to $44 Mn in 2030 with a CAGR of 5.25% for the forecasted year 2022-30. The elderly in the Netherlands are becoming more prevalent, which increases their chance of developing coronary artery disease. The demand for coronary stents and other cardiovascular devices is anticipated to rise as the population continues to age. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Hy2Care B.V., InnoSer, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare, and Philips Healthcare.
Netherlands's Contraceptive Devices Market is expected to witness growth from $34 Mn in 2022 to $64 Mn in 2030 with a CAGR of 8.50% for the forecasted year 2022-30. In the Netherlands, as consumers become more aware of the benefits of family planning and contraception, there is an increase in the demand for contraceptive devices. The market is segmented by type and by gender. Some key players in this market include Hy2Care B.V., InnoSer, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
This report presents a strategic analysis of the Morocco Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Morocco Medical Devices Market, offering unmatched value, accuracy, and expert insights.
This report presents a strategic analysis of the Middle East 3D Printing Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Middle East 3D Printing Medical Devices Market, offering unmatched value, accuracy, and expert insights.
Mexico's ENT Devices Market is projected to grow from $350 Mn in 2022 to $550 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Mexico ENT devices market include ACI Medical, Gamma Medical Instruments, and LAB-MED.
Mexico's ECG Equipment Market is expected to witness growth from $134 Mn in 2022 to $239 Mn in 2030 with a CAGR of 7.55% for the forecasted year 2022-2030. A growing number of people in Mexico are reaching the age of 65 to retire as the country's population increases. To monitor and treat aging-related health issues like heart disease, this demographic trend is boosting demand for healthcare services and diagnostic instruments, particularly ECG equipment. The market is segmented by product type and by end user. Some key players in this market include BIOMEDICA MEXICANA, Medstent, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.
Mexico's Coronary Stents Market is expected to witness growth from $170 Mn in 2022 to $250 Mn in 2030 with a CAGR of 5.00% for the forecasted year 2022-30. In Mexico, where the rate and frequency of heart failure are extremely high, it is a significant public health concern. This expands the market for coronary stents and other CAD treatments. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include BIOMEDICA MEXICANA, Medstent, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
Mexico's Contraceptive Devices Market is expected to witness growth from $194 Mn in 2022 to $365 Mn in 2030 with a CAGR of 8.25% for the forecasted year 2022-30. In Mexico, the necessity for efficient family planning and the country's expanding population are driving up the need for contraceptive devices. The market is segmented by type and by gender. Some key players in this market include Laboratorios Grin, Probiomed, Industria Farmacéutica Andrómaco, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
Malaysia's Neurology Devices Market is expected to witness growth from $20 Mn in 2022 to $xx Mn in 2030 with a CAGR of xx% for the forecasted year 2022-30. The expansion of the neurology devices market in Malaysia is being fueled by the development of cutting-edge neurology devices such as brain-computer interfaces and cutting-edge neuroimaging technologies. The market is segmented by treatment, route of administration, age group, and by distribution channel. Major Key players in Malaysia's neurology devices market include Medtronic, Abbott Laboratories, Nihon Kohden, Natus Medical, and B. Braun Melsungen.
Malaysia's ENT Devices Market is projected to grow from $40 Mn in 2022 to $60 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Malaysia ENT devices market include Meditop, Meditrade, and ENTtech Medical Solutions.
Malaysia's Diabetes Devices Market is expected to witness growth from $37 Mn in 2022 to $65 Mn in 2030 with a CAGR of 7.40% for the forecasted year 2022-30. Patients travel from all over the world to Malaysia for medical tourism, which is well-recognized for doing so. A key factor in the expansion of the diabetes device market is the availability of high-quality diabetes devices and services for patients seeking medical treatment in the country. The market is segmented by type and by the end user. Some key players in this market include GA2 Medical, Transmedia Healthcare, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care, and Dexcom.
Malaysia's Coronary Stents Market is expected to witness growth from $18 Mn in 2022 to $27 Mn in 2030 with a CAGR of 4.95% for the forecasted year 2022-30. The introduction of coronary stents as a treatment option for CAD is being driven by a rising desire for minimally invasive procedures in Malaysia because these procedures are less invasive and have quicker recovery times than conventional surgical procedures. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Qualitas Medical Group, GA2 Medical, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare, and Philips Healthcare.
Malaysia's Contraceptive Devices Market is expected to witness growth from $21 Mn in 2022 to $39 Mn in 2030 with a CAGR of 8.20% for the forecasted year 2022-30. To encourage family planning and reproductive health, the Malaysian government has taken several actions, including subsidizing contraceptive products and services. This funding has boosted the demand for contraceptive devices. The market is segmented by type and by gender. Some key players in this market include Karex Berhad, BP Healthcare Group, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
This report presents a strategic analysis of the Libya Diabetes Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Libya Diabetes Devices Market, offering unmatched value, accuracy, and expert insights.
This report presents a strategic analysis of the Lebanon Cardiac Surgery Instruments Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Lebanon Cardiac Surgery Instruments Market, offering unmatched value, accuracy, and expert insights.
Kenya's ENT Devices Market is projected to grow from $20 Mn in 2022 to $30 Mn by 2030, registering a CAGR of 6.9% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Kenya ENT devices market include Phoenix Equipment, Toda Medical Supplies, and Megascope Healthcare.
Kenya's Coronary Stents Market is expected to witness growth from $8 Mn in 2022 to $12 Mn in 2030 with a CAGR of 5.85% for the forecasted year 2022-30. In Kenya, both the incidence and prevalence of coronary artery disease are rising. Since CAD is one of the main conditions requested for the implantation of coronary stents, this is a significant market growth driver for manufacturers of coronary stents. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Apicalmed, Asterisk, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare, and Philips Healthcare.
Kenya's Contraceptive Devices Market is expected to witness growth from $9 Mn in 2022 to $18 Mn in 2030 with a CAGR of 9.10% for the forecasted year 2022-30. Kenya's growing demographics, urbanization, and shifting lifestyles are all contributing to an increase in the demand for family planning services. As a result, there has been an increase in the usage of contraceptive methods for family planning. The market is segmented by type and by gender. Some key players in this market include Surgipharm Kenya, Omsai Distributors, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
This report presents a strategic analysis of the Kenya 3D Printing Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Kenya 3D Printing Medical Devices Market, offering unmatched value, accuracy, and expert insights.
Japan's Neurology Device Market size is at around $784.44 Mn in 2022 and is projected to reach $1484.53 Bn in 2030, exhibiting a CAGR of 8.3% during the forecast period. Artificial intelligence machine learning in neurology diagnostics, and 3D printing for customizing and improving neurology devices are the major trends in medical devices in Japan reigned by players like B. Braun Melsungen, Stryker, and Boston Scientific. This report by Insights10 is segmented by product type like neurostimulation, interventional neurology, neurosurgery devices, and neuro-endoscopes, and by the end user.
Japan's ENT Devices Market is projected to grow from $1.44 Bn in 2022 to $2.34 Bn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Japan ENT devices market include Olympus Corporation, Fukuda Denshi, and HOYA Corporation.
Japan's Coronary Stents Market is expected to witness growth from $702 Mn in 2022 to $1058 Mn in 2030 with a CAGR of 5.25% for the forecasted year 2022-30. The early identification and treatment of coronary artery disease in Japan are projected to be driven by increased access to healthcare and improved heart health awareness, opening up the potential for manufacturers in the coronary stent market. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Terumo Corporation, Fukuda, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.
Italy's ENT Devices Market is projected to grow from $560 Mn in 2022 to $840 Mn by 2030, registering a CAGR of 5.3% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Italy ENT devices market include Medtronic Italia, Grandi, and Moria.